Skip to Content
MilliporeSigma
All Photos(2)

Documents

719714

Sigma-Aldrich

2,6-Diisopropylphenylboronic acid

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Empirical Formula (Hill Notation):
C12H19BO2
CAS Number:
363166-79-4
Molecular Weight:
206.09
MDL number:
MFCD16876786
UNSPSC Code:
12352103
PubChem Substance ID:
329763674
NACRES:
NA.22

form

solid

mp

167-172 °C

SMILES string

CC(C)c1cccc(C(C)C)c1B(O)O

InChI

1S/C12H19BO2/c1-8(2)10-6-5-7-11(9(3)4)12(10)13(14)15/h5-9,14-15H,1-4H3

InChI key

UPXGMXMTUMCLGD-UHFFFAOYSA-N

Application

2,6-Diisopropylphenylboronic acid can be used as a reactant:
  • In the Pd-catalyzed Suzuki-Miyaura cross-coupling reactions.
  • To synthesis potent propargyl-based inhibitors of the Cryptosporidium dihydrofolate reductase (DHFR) enzyme.
  • To prepare boralumoxane applicable in the activation of zirconocene catalyst for the polymerization ethene.

Storage Class

11 - Combustible Solids

wgk_germany

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 1

1 of 1

Phenylboronic acid 95%

Sigma-Aldrich

P20009

Phenylboronic acid

Synthesis and structural characterisation of a boralumoxane capable of activating a zirconocene ethene polymerisation catalyst
Richter B, et al.
Chemical Communications (Cambridge, England), (14), 1286-1287 (2001)
David B Bolstad et al.
Journal of medicinal chemistry, 51(21), 6839-6852 (2008-10-07)
Cryptosporidiosis is an emerging infectious disease that can be life-threatening in an immune-compromised individual and causes gastrointestinal distress lasting up to 2 weeks in an immune-competent individual. There are few therapeutics available for effectively treating this disease. We have been
Catalytic hydrosilylation of alkenes by iron complexes containing terpyridine derivatives as ancillary ligands
Kamata K, et al.
Organometallics, 31(10), 3825-3828 (2012)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service